Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Salmonella Typhimurium surface antigens represent a diverse group of molecules located on the outer membrane and surface of the Gram-negative bacterium Salmonella enterica serovar Typhimurium. These antigens include lipopolysaccharides (LPS, containing the immunodominant O-antigen), outer membrane proteins (OMPs like OmpA, OmpC, and OmpD), and flagellar proteins (such as FliC and FliK). Biologically, these surface structures are critical for bacterial integrity, motility, host cell adhesion, invasion, and evasion of the host immune system. In the context of human and veterinary medicine, they serve as primary targets for vaccine development and passive immunotherapy. Vaccines such as the bivalent iNTS-GMMA (utilizing generalized modules for membrane antigens) and live-attenuated strains like CVD 1926 target these antigens to elicit protective humoral and cell-mediated immune responses. Additionally, therapeutic monoclonal antibodies (e.g., F1D4 and B7D4) are being developed to target specific surface proteins to inhibit bacterial motility, adhesion, and invasion, thereby preventing or treating severe salmonellosis and associated systemic infections.
Active immunization via vaccines stimulates the host immune system to produce protective antibodies (such as anti-O-antigen IgG) and activate T-cell-mediated immunity against Salmonella Typhimurium. Passive immunization using monoclonal antibodies targets specific surface antigens (e.g., FliK or BcsZ) to neutralize the pathogen, inhibit bacterial motility, block host cell adhesion and invasion, and promote opsonophagocytic clearance by host immune cells.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella Typhimurium surface antigens.